Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06245369 · ClinicalTrials.gov registry record · NA
SWITCH Diets Study: Self-monitoring With Internet Technology to Choose Healthy Diets
A NA study, sponsored by University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 106
- Enrollment target
NCT06245369: Completed NA study, sponsored by University of South Carolina.
NCT06245369 is a NA study that has completed, run by University of South Carolina. The registered enrollment target is 106 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06245369, a NA study, has completed, sponsored by University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
Study Summary
The goal of the Self-monitoring With Internet Technology to Choose Healthy Diets (SWITCH) study is to examine a 12-week remotely delivered program designed to help adults adopt a healthy dietary lifestyle and lose weight in a diverse cohort of adults with overweight/obesity. The intervention uses a self-determination theory framework to provide a deeper understanding of the factors that influence dietary behavior within the context of tracking. This study incorporates autonomy-supportive strategies to encourage participants to feel more in control of their dietary choices and will provide information and resources to boost participant's competence in achieving their dietary goals. The intervention includes weekly learning modules to support healthy eating and weight loss and daily dietary tracking with visual feedback, all accessible within the SWITCH app.
Primary Outcome
Change in Healthy Eating Index from baseline to 12 weeks as assessed by dietary recalls.
Interventions
- BEHAVIORAL learning modules (within app)
- BEHAVIORAL SWITCH app (self-regulation features) - Experimental
- BEHAVIORAL SWITCH app (self-regulation features) - Comparator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2024-04-15 |
| Est. Completion | 2025-03-18 |
| Phase | NA |
What the finished NCT06245369 record still lists
NCT06245369 is an interventional study that assigns participants to a tested intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 3 interventions - of which learning modules (within app) is the first listed.
NCT06245369 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06245369 about?
NCT06245369 is a clinical study titled "SWITCH Diets Study: Self-monitoring With Internet Technology to Choose Healthy Diets". The goal of the Self-monitoring With Internet Technology to Choose Healthy Diets (SWITCH) study is to examine a 12-week remotely delivered program designed to help adults adopt a healthy dietary lifestyle and lose weight in a diverse cohort of adults with overweight/obesity. The intervention uses a...
What is the current status of trial NCT06245369?
This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2024-04-15. Estimated completion is 2025-03-18.
What interventions are being tested in trial NCT06245369?
The interventions under investigation include: learning modules (within app) (BEHAVIORAL), SWITCH app (self-regulation features) - Experimental (BEHAVIORAL), SWITCH app (self-regulation features) - Comparator (BEHAVIORAL).
Who is sponsoring clinical trial NCT06245369?
This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06245369's enrollment target sits among peer trials
106 830th of 2000 higher than 1,167 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03181048 · 106 participants · NA
Clinical Trial of Concomitant Hip Arthroscopy During PAO
- NCT04682158 · 106 participants · Phase 2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- NCT04724018 · 106 participants · Phase 1
Sacituzumab Govitecan Plus EV in Metastatic UC
- NCT04798274 · 106 participants · NA
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI